Connect with us

Headlines

Pharma Firm Gets $110M in Financing to Support Eyecare Drugs

mm

Published

on

It’s partnering with Athyrium.

WALTHAM, MA — Kala Pharmaceuticals Inc. announced the closing of a $110 million credit facility with funds managed by Athyrium Capital Management LP, a healthcare-focused investment firm.

Kala said in a press release that it will use the money to develop eyecare-related drugs. Kala (NASDAQ: KALA) is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle technology.

“We are pleased to be partnering with Athyrium and to have their support and confidence in INVELTYS for the treatment of inflammation and pain following ocular surgery and KPI-121 0.25% for dry eye disease,” said Mark Iwicki, chairman, president and CEO of Kala. “We expect this financing to support Kala’s efforts to achieve significant milestones, including the NDA filing for KPI-121 0.25% for dry eye disease by the end of 2018, the launch of INVELTYS in early 2019, and topline results for the STRIDE-3 trial of KPI-121 0.25% expected in Q4 2019.”

Laurent D. Hermouet, partner at Athyrium, said INVELTYS “has an efficacy, safety and dosing profile which should make it a desirable treatment option” for patients following ocular surgery. Hermoue said KPI-121 0.25% “could become a standard of care for the treatment of dry eye flares.”

Advertisement

 

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular